Immuno-oncology agents for cancer therapySubscription
Abstract: Until recently, cancer therapy comprised of four main types of treatment: surgery, radiotherapy, chemotherapy and targeted therapy. Over the past decade, immuno-oncology (IO) has emerged as a novel and important approach to cancer treatment through the stimulation of the body’s own immune system to kill cancer cells. This newly recognised method of treating cancer is rapidly developing, with many accelerated approvals by the US Food and Drug Administration and European Medicines ...
Effective detection and management of hypertension through community pharmacy in EnglandSubscription
Management of hypertension does not routinely occur in English pharmacies, despite community pharmacy being an ideal place for screening to take place. By examining and learning from the evidence, pharmacies in England can help patients maintain ideal blood pressure levels and improve health outcomes.
Prevention of medication-related osteonecrosis of the jawSubscription
Severe bone damage in the jaw occurs in some people as an adverse reaction to certain medicines commonly used in the treatment of cancer and osteoporosis. There are a range of settings where pharmacists can contribute to the prevention of this painful and difficult-to-treat condition.
Pharmacokinetic considerations and challenges in oral anticancer drug therapySubscription
A review of the pros and cons of oral anticancer drug therapy, as well as the pharmacokinetic barriers and potential solutions to oral chemotherapy in the home.
Evaluation of the impact of pharmacist polypharmacy reviews within the Govan Social and Healthcare Integration Partnership (SHIP) project Subscription
Providing pharmacist-led medicines reviews to patients in one of the most deprived areas in Scotland to reduce the health inequality gap.
Providing medicines adherence support to areas of high deprivation in England: community pharmacists’ experienceSubscription
Semi-structured interviews assessing pharmacists’ experiences of providing interventions, products and services that support medicines adherence.
Local implementation of national guidance on management of common infections in primary care in EnglandSubscription
Local adoption and adaptation of national antimicrobial prescribing guidance in primary care.
Reducing inappropriate polypharmacy in primary care through pharmacy-led interventionsSubscription
A pharmacy-led medicines optimisation team in a GP surgery setting reduced inappropriate polypharmacy, achieved cost savings of £103,975 and improved quality of prescribing for patients.
Evaluation of the Portsmouth medicines advice at home serviceSubscription
A Portsmouth-based medicines advice at home service highlights the impact of pharmacist-led interventions.
Opioid use disorder: adherence to prescribed medicines in community pharmacy Subscription
A cross-sectional survey assessing adherence medication-assisted treatment for opioid use disorder, and the predictors of risk of poor adherence.
Pharmaceutical care to medical patients in the emergency department: a service evaluationSubscription
An evaluation of a new hospital pharmacy service that introduces pharmaceutical care earlier after admission to the emergency department.
Responding to disruptions in the pharmaceutical supply chainSubscription
Economic, manufacturing and regulatory factors can affect drug shortages and supply chain disruption. By using a mixed-methods approach involving an online survey, semi-structured interviews and three targeted focus groups aimed at acute care hospitals in England, Wales, Northern Ireland and Ireland, this study determined that over half of the responding acute care hospitals did not have 76–100% of medicine lines fulfilled within 8 weeks of a disruption in the supply chain.
